Rhenman & Partners Asset Management AB as of June 30, 2023
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 83 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 4.0 | $38M | 81k | 468.98 | |
| BioMarin Pharmaceutical (BMRN) | 3.5 | $33M | 380k | 86.68 | |
| Cigna Corp (CI) | 3.4 | $32M | 115k | 280.60 | |
| Boston Scientific Corporation (BSX) | 3.3 | $31M | 580k | 54.09 | |
| McKesson Corporation (MCK) | 3.2 | $30M | 71k | 427.31 | |
| UnitedHealth (UNH) | 3.0 | $29M | 60k | 480.64 | |
| Abbott Laboratories (ABT) | 2.9 | $27M | 249k | 109.02 | |
| Medtronic SHS (MDT) | 2.7 | $26M | 292k | 88.10 | |
| Regeneron Pharmaceuticals (REGN) | 2.7 | $25M | 35k | 718.54 | |
| Becton, Dickinson and (BDX) | 2.6 | $25M | 95k | 264.01 | |
| Anthem (ELV) | 2.6 | $25M | 56k | 444.29 | |
| Tenet Healthcare Corp Com New (THC) | 2.5 | $24M | 290k | 81.38 | |
| AmerisourceBergen (COR) | 2.4 | $23M | 119k | 192.43 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.4 | $22M | 64k | 351.91 | |
| Merck & Co (MRK) | 2.3 | $22M | 190k | 115.39 | |
| Humana (HUM) | 2.2 | $21M | 46k | 447.13 | |
| Cooper Cos Com New | 2.1 | $20M | 53k | 383.43 | |
| Abbvie (ABBV) | 2.1 | $20M | 150k | 134.73 | |
| Zimmer Holdings (ZBH) | 2.1 | $20M | 138k | 145.60 | |
| Hca Holdings (HCA) | 2.1 | $20M | 65k | 303.48 | |
| Biogen Idec (BIIB) | 1.9 | $18M | 65k | 284.85 | |
| Gilead Sciences (GILD) | 1.9 | $18M | 234k | 77.07 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.9 | $18M | 145k | 123.97 | |
| Apellis Pharmaceuticals (APLS) | 1.8 | $17M | 190k | 91.10 | |
| CVS Caremark Corporation (CVS) | 1.8 | $17M | 248k | 69.13 | |
| EXACT Sciences Corporation (EXAS) | 1.7 | $16M | 175k | 93.90 | |
| Shockwave Med | 1.7 | $16M | 56k | 285.41 | |
| Intuitive Surgical Com New (ISRG) | 1.6 | $15M | 44k | 341.94 | |
| Danaher Corporation (DHR) | 1.5 | $14M | 60k | 240.00 | |
| ImmunoGen | 1.5 | $14M | 750k | 18.87 | |
| Privia Health Group (PRVA) | 1.3 | $12M | 460k | 26.11 | |
| Axonics Modulation Technolog (AXNX) | 1.2 | $12M | 230k | 50.47 | |
| Alkermes SHS (ALKS) | 1.2 | $11M | 350k | 31.30 | |
| Iqvia Holdings (IQV) | 1.1 | $11M | 47k | 224.77 | |
| Procept Biorobotics Corp (PRCT) | 1.0 | $9.9M | 279k | 35.35 | |
| Natera (NTRA) | 1.0 | $9.7M | 200k | 48.66 | |
| Dynavax Technologies Corp Com New (DVAX) | 1.0 | $9.0M | 700k | 12.92 | |
| Alnylam Pharmaceuticals (ALNY) | 0.9 | $8.5M | 45k | 189.94 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.9 | $8.4M | 100k | 83.92 | |
| 10x Genomics Cl A Com (TXG) | 0.8 | $7.6M | 136k | 55.84 | |
| Karuna Therapeutics Ord | 0.8 | $7.6M | 35k | 216.85 | |
| Biontech Se Sponsored Ads (BNTX) | 0.8 | $7.6M | 70k | 107.93 | |
| Harmony Biosciences Hldgs In (HRMY) | 0.8 | $7.4M | 210k | 35.19 | |
| Outset Med (OM) | 0.8 | $7.2M | 331k | 21.87 | |
| Veeva Sys Cl A Com (VEEV) | 0.7 | $6.9M | 35k | 197.73 | |
| Glaukos (GKOS) | 0.7 | $6.8M | 95k | 71.21 | |
| Molina Healthcare (MOH) | 0.7 | $6.5M | 22k | 301.24 | |
| Cytokinetics Com New (CYTK) | 0.7 | $6.5M | 200k | 32.62 | |
| Intra Cellular Therapies (ITCI) | 0.6 | $6.0M | 95k | 63.32 | |
| Iovance Biotherapeutics (IOVA) | 0.6 | $6.0M | 850k | 7.04 | |
| Alignment Healthcare (ALHC) | 0.6 | $5.8M | 1.0M | 5.75 | |
| Xencor (XNCR) | 0.6 | $5.6M | 225k | 24.97 | |
| R1 RCM (RCM) | 0.6 | $5.5M | 300k | 18.45 | |
| Moderna (MRNA) | 0.6 | $5.5M | 45k | 121.50 | |
| Immunocore Hldgs Ads (IMCR) | 0.6 | $5.4M | 89k | 59.96 | |
| Mirati Therapeutics | 0.5 | $5.1M | 140k | 36.13 | |
| Inspire Med Sys (INSP) | 0.5 | $5.0M | 15k | 324.64 | |
| Royalty Pharma Shs Class A (RPRX) | 0.5 | $4.6M | 150k | 30.74 | |
| Evolent Health Cl A (EVH) | 0.5 | $4.4M | 145k | 30.30 | |
| Health Catalyst (HCAT) | 0.4 | $4.0M | 320k | 12.50 | |
| Bio-techne Corporation (TECH) | 0.4 | $3.9M | 48k | 81.63 | |
| Neurocrine Biosciences (NBIX) | 0.4 | $3.8M | 40k | 94.30 | |
| Nuvalent Inc-a (NUVL) | 0.4 | $3.6M | 86k | 42.17 | |
| Meiragtx Holdings (MGTX) | 0.4 | $3.6M | 539k | 6.72 | |
| West Pharmaceutical Services (WST) | 0.4 | $3.4M | 9.0k | 382.47 | |
| Revance Therapeutics (RVNC) | 0.3 | $3.1M | 123k | 25.31 | |
| Olink Hldg Ab Sponsored Ads (OLK) | 0.3 | $3.1M | 166k | 18.75 | |
| Viking Therapeutics (VKTX) | 0.3 | $2.9M | 180k | 16.21 | |
| Axsome Therapeutics (AXSM) | 0.3 | $2.9M | 40k | 71.86 | |
| Edwards Lifesciences (EW) | 0.3 | $2.7M | 29k | 94.33 | |
| Relay Therapeutics (RLAY) | 0.3 | $2.4M | 190k | 12.56 | |
| Bridgebio Pharma (BBIO) | 0.2 | $2.3M | 135k | 17.20 | |
| Arvinas Ord (ARVN) | 0.2 | $2.1M | 85k | 24.82 | |
| Intellia Therapeutics (NTLA) | 0.2 | $2.0M | 50k | 40.78 | |
| Immunovant (IMVT) | 0.2 | $1.9M | 100k | 18.97 | |
| Igm Biosciences (IGMS) | 0.2 | $1.8M | 200k | 9.23 | |
| Inmune Bio Ord (INMB) | 0.2 | $1.6M | 178k | 9.08 | |
| Allogene Therapeutics (ALLO) | 0.2 | $1.5M | 300k | 4.97 | |
| Tg Therapeutics (TGTX) | 0.1 | $1.4M | 55k | 24.84 | |
| Mersana Therapeutics (MRSN) | 0.1 | $1.3M | 400k | 3.29 | |
| Essa Pharma Com New (EPIX) | 0.1 | $963k | 357k | 2.70 | |
| Rigel Pharmaceuticals Com New | 0.0 | $327k | 254k | 1.29 | |
| Thermo Fisher Scientific (TMO) | 0.0 | $261k | 500.00 | 521.75 |
